搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
搜狐
3 分钟
GLP-1 赛道已进入 "拼产能、拼创新、拼生态" 的 3.0 时代
这场关乎全民健康的 "减重大战",正从政策顶层设计走向全民科学实践。 司美格鲁肽(Wegovy):作为全球首个获批用于肥胖症的长效 GLP-1 受体激动剂,Wegovy 凭借 SELECT 心血管结局试验的惊艳数据掀起行业风暴:在心血管高危人群中,每周注射 2.4mg 可使体重降低 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Deportation order blocked
US launches strikes in Yemen
Electrical fire halts show
Man wins $50M over burns
SK: Massive rallies erupt
Withdraws nomination
Top intelligence agency visit
US expels SA ambassador
Felony gun possession arrest
Permanently shuts route
RU, UKR launch attacks
Laceration hazard recall
Influential WY senator dies
Israeli attack in Gaza
Senate confirmation hearing
ISIS leader killed in Iraq
Cuba suffers power outage
Severe weather outbreak
Consumer sentiment drops
Influencer leaves Australia
Pleads not guilty
Kupp signs with Seahawks
Second protester arrested
Coffee creamer recall
Child abuse images sentence
Texas measles outbreak
Syed formally resentenced
Gold rises to new heights
Chiefs sign Tillery
反馈